James Meyers

James Meyers

Director/Miembro de la Junta en CYTOMX THERAPEUTICS, INC. .

Fortuna: 12 309 $ al 31/08/2026

60 años
Health Technology
Commercial Services
Consumer Services

Perfil

Mr. James R.
Meyers
is an Independent Director at Vera Therapeutics, Inc., a Chairman at IntegriChain, Inc., an Independent Director at Sangamo Therapeutics, Inc. and an Independent Director at CytomX Therapeutics, Inc. He is on the Board of Directors at Vera Therapeutics, Inc., Sangamo Therapeutics, Inc., CytomX Therapeutics, Inc., Biotechnology Innovation Organization, California Biomedical Innovation Alliance and Pulmocide Ltd. Mr. Meyers was previously employed as a President & Chief Executive Officer by IntraBio, Inc., an Independent Director by Arbutus Biopharma Corp., and an Executive VP-Worldwide Commercial Operations by Gilead Sciences, Inc. He received his undergraduate degree from Boston College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/04/2026 74.600 ( 0,02 % ) 12 309 $ 31/08/2026
17/06/2026 0 ( -.--% ) - $ 31/08/2026
21/05/2026 0 ( -.--% ) - $ 31/08/2026

Cargos activos de James Meyers

EmpresasCargoInicio
CYTOMX THERAPEUTICS, INC. Director/Miembro de la Junta 20/12/2018
SANGAMO THERAPEUTICS, INC. Director/Miembro de la Junta 22/11/2019
VERA THERAPEUTICS, INC. Director/Miembro de la Junta 25/11/2025
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Presidente 01/03/2024

Antiguos cargos conocidos de James Meyers.

EmpresasCargoFin
ARBUTUS BIOPHARMA CORPORATION Director/Miembro de la Junta 24/02/2025
Director Ejecutivo 01/01/2024
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de James Meyers.

Formación de James Meyers.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

86

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN